-47.6%
BMNR vs GSK
+21.8%
-69.4%
-78.9%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | GSK | Excess | Alpha |
|---|---|---|---|---|
| 1D | +3.4% | 0.0% | +3.4% | +3.4% |
| 7D | +0.2% | -3.5% | +3.8% | -0.3% |
| 30D | +39.9% | -3.4% | +43.4% | +39.2% |
| 3M | +51.5% | -8.1% | +59.6% | +49.8% |
| 6M | +18.9% | -11.1% | +30.0% | +16.4% |
| YTD | -7.8% | +0.7% | -8.5% | -5.2% |
| 1Y | -47.6% | +20.1% | -67.8% | -41.4% |
| All | -47.6% | +21.8% | -69.4% | -41.4% |
Cumulative growth
Daily Returns
Daily percentage return beside GSK.
Daily Out/Under-Performance
Portfolio return minus GSK return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling